AI English summary of an SEC filing — figures as filed
American Water Works AWKThe company said that at a meeting on October 29, 2024, its board increased the board's size from 9 to 10 members and, on the recommendation of the Nominating/Corporate Governance Committee, appointed Stuart M. McGuigan as an independent director. The appointment took effect immediately, and his term runs until the 2025 annual shareholder meeting.
Key points
AI summaryThe company said that at a meeting on October 29, 2024, its board increased the board's size from 9 to 10 members and, on the recommendation of the Nominating/Corporate Governance Committee, appointed Stuart M. McGuigan as an independent director. The appointment took effect immediately, and his term runs until the 2025 annual shareholder meeting.
The company said Mr. McGuigan will receive an annual base cash retainer of $120,000, paid quarterly and prorated for his term of service. He will also receive director stock units worth a prorated share of $165,000 in annual equity compensation, and those units vest immediately.
The company said the Nominating Committee has deferred its recommendations on Mr. McGuigan's committee assignments until the 2025 annual committee review process. Mr. McGuigan also disclosed that he has no direct or indirect material interest in any transaction requiring reporting under Item 404(a).
The company said in a press release that Mr. McGuigan has more than 38 years of information technology and management experience and most recently served as Global Chief Information Officer of Fresenius Medical Care. It also said he oversaw $2.4 billion in technology programs as Chief Information Officer at the U.S. Department of State.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Board Expands to Add New Independent Director
The company said that at a meeting on October 29, 2024, its board increased the board's size from 9 to 10 members and, on the recommendation of the Nominating/Corporate Governance Committee, appointed Stuart M. McGuigan as an independent director. The appointment took effect immediately, and his term runs until the 2025 annual shareholder meeting.
Source · Based on the filing body and exhibits
Compensation Terms for New Director
The company said Mr. McGuigan will receive an annual base cash retainer of $120,000, paid quarterly and prorated for his term of service. He will also receive director stock units worth a prorated share of $165,000 in annual equity compensation, and those units vest immediately.
Source · Based on the filing body and exhibits
Committee Assignments Deferred; No Related-Party Interest
The company said the Nominating Committee has deferred its recommendations on Mr. McGuigan's committee assignments until the 2025 annual committee review process. Mr. McGuigan also disclosed that he has no direct or indirect material interest in any transaction requiring reporting under Item 404(a).
Source · Based on the filing body and exhibits
Background of New Director
The company said in a press release that Mr. McGuigan has more than 38 years of information technology and management experience and most recently served as Global Chief Information Officer of Fresenius Medical Care. It also said he oversaw $2.4 billion in technology programs as Chief Information Officer at the U.S. Department of State.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…